Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

The era of combination therapy in myeloma.

Lonial S, Kaufman JL.

J Clin Oncol. 2012 Jul 10;30(20):2434-6. doi: 10.1200/JCO.2011.40.6967. Epub 2012 May 14. No abstract available.

PMID:
22585685
[PubMed - indexed for MEDLINE]
Free Article
2.

Autologous transplantation for multiple myeloma.

Harousseau JL.

Ann Oncol. 2008 Sep;19 Suppl 7:vii128-33. doi: 10.1093/annonc/mdn449. No abstract available.

PMID:
18790933
[PubMed - indexed for MEDLINE]
Free Article
3.

Lenalidomide for multiple myeloma.

Bertolini F.

N Engl J Med. 2012 Aug 9;367(6):573; author reply 573-5. doi: 10.1056/NEJMc1206734#SA1. No abstract available.

PMID:
22873542
[PubMed - indexed for MEDLINE]
4.

Lenalidomide in myeloma--a high-maintenance friend.

Badros AZ.

N Engl J Med. 2012 May 10;366(19):1836-8. doi: 10.1056/NEJMe1202819. No abstract available.

PMID:
22571206
[PubMed - indexed for MEDLINE]
5.

The refractory patient: new treatment options.

Schuster MW.

Oncology (Williston Park). 2003 Oct;17(10):1333-5. No abstract available.

PMID:
14606360
[PubMed - indexed for MEDLINE]
6.

Advances in biology and treatment of multiple myeloma.

Ludwig H.

Ann Oncol. 2005;16 Suppl 2:ii106-12. Review. No abstract available.

PMID:
15958439
[PubMed - indexed for MEDLINE]
Free Article
7.

Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma.

Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B.

Bone Marrow Transplant. 2002 Mar;29(6):544. No abstract available.

PMID:
11960281
[PubMed - indexed for MEDLINE]
Free Article
8.

Unusual multiple myeloma cutaneous manifestation following nonmyeloablative allogeneic stem cell transplantation.

Subbiah S, O'Connell F, Kobraei KB, Ramos-Caro FA, Moreb JS.

Clin Adv Hematol Oncol. 2009 Dec;7(12):800-2. No abstract available.

PMID:
20332750
[PubMed - indexed for MEDLINE]
9.

Thalidomide maintenance in multiple myeloma: certainties and controversies.

Cavo M, Pantani L, Tacchetti P, Pallotti MC, Brioli A, Petrucci A, Zamagni E, Tosi P.

J Clin Oncol. 2009 Nov 10;27(32):e186-7; author reply e188. doi: 10.1200/JCO.2009.24.0150. Epub 2009 Sep 21. No abstract available.

PMID:
19770366
[PubMed - indexed for MEDLINE]
Free Article
10.

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.

Kim HJ, Yoon SS, Lee DS, Sohn SK, Eom HS, Lee JL, Chung JS, Kim K, Suh C, Won JH, Kim JS, Park JS, Kang HJ, Seong CM, Kim CS, Lee SJ, Lee JH.

Ann Hematol. 2012 Feb;91(2):249-56. doi: 10.1007/s00277-011-1298-9. Epub 2011 Jul 26.

PMID:
21789621
[PubMed - indexed for MEDLINE]
11.

A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.

Hönemann D, Prince HM, Seymour JF, Wolf MM, Westerman D, Januszewicz EH.

Leuk Lymphoma. 2005 Jun;46(6):945-7. No abstract available.

PMID:
16019544
[PubMed - indexed for MEDLINE]
12.

Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?

van Rhee F.

Nat Clin Pract Oncol. 2008 Feb;5(2):70-1. Epub 2007 Nov 6. No abstract available.

PMID:
17984985
[PubMed - indexed for MEDLINE]
13.

Researchers debate best use of stem cell transplants in patients with multiple myeloma.

Rowan K.

J Natl Cancer Inst. 2009 Dec 2;101(23):1608-11. doi: 10.1093/jnci/djp434. Epub 2009 Nov 12. No abstract available.

PMID:
19910555
[PubMed - indexed for MEDLINE]
Free Article
14.

Recent trends in the management of newly diagnosed multiple myeloma.

Reece DE.

Curr Opin Hematol. 2009 Jul;16(4):306-12. doi: 10.1097/MOH.0b013e32832e3154. Review.

PMID:
19491669
[PubMed - indexed for MEDLINE]
15.

[Multiple myeloma -- therapy].

Jung W, Zettl F, Schroers R.

Dtsch Med Wochenschr. 2005 Feb 11;130(6):283-6; quiz 287-90. German. No abstract available.

PMID:
15692903
[PubMed - indexed for MEDLINE]
16.

Autologous peripheral stem cell transplantation for multiple myeloma in a patient with a 10 year-old kidney transplant: case report and clinical issues.

Rego F, Alcântara P, Buinho F, Araújo F, Santos JM, Parreira A, da Costa FL.

Transplant Proc. 2003 May;35(3):1102-4. No abstract available.

PMID:
12947876
[PubMed - indexed for MEDLINE]
17.

Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.

Patriarca F, Sperotto A, Prosdocimo S, Geromin A, Zaja F, Fanin R.

Haematologica. 2003 May;88(5):597-9. No abstract available.

PMID:
12745281
[PubMed - indexed for MEDLINE]
Free Article
18.

Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients.

Fassas AB, Spencer T, Desikan R, Zangari M, Anaissie E, Barlogie B, Tricot G.

Br J Haematol. 2002 Oct;119(1):164-8.

PMID:
12358921
[PubMed - indexed for MEDLINE]
19.

A new standard of care for elderly patients with myeloma.

Palumbo A, Boccadoro M.

Lancet. 2007 Oct 6;370(9594):1191-2. No abstract available. Erratum in: Lancet. 2008 Mar 22;371(9617):986.

PMID:
17920906
[PubMed - indexed for MEDLINE]
20.

Multiple myeloma patients experience high response rate with new three-drug combination.

[No authors listed]

Cancer Biol Ther. 2009 Dec;8(24):ii-iii. No abstract available.

PMID:
20217915
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk